A KOL interview highlighting the current treatment landscape in AML and challenges with treatment selection and reimbursement. Unmet needs in AML are also discussed, as well as pipeline therapies currently in development across multiple lines of treatment and settings. 

This interview was conducted on 22 July 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.